Carson Wealth (CWM LLC)’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.1K Buy
1,849
+138
+8% +$5.84K ﹤0.01% 3657
2025
Q4
$79K Buy
1,711
+87
+5% +$3.64K ﹤0.01% 3241
2025
Q3
$57K Buy
1,624
+217
+15% +$7.54K ﹤0.01% 3421
2025
Q2
$42K Buy
1,407
+1,153
+454% +$32.9K ﹤0.01% 3408
2025
Q1
$8K Sell
254
-97
-28% -$2.96K ﹤0.01% 4202
2024
Q4
$10K Sell
351
-1,140
-76% -$37.7K ﹤0.01% 3849
2024
Q3
$58K Buy
1,491
+736
+97% +$26.2K ﹤0.01% 2575
2024
Q2
$24K Buy
755
+738
+4,341% +$25.6K ﹤0.01% 2988
2024
Q1
$1K Buy
17
+5
+42% +$175 ﹤0.01% 4100
2023
Q4
$0 Sell
12
-49
-80% -$1.23K ﹤0.01% 4181
2023
Q3
$1K Buy
61
+6
+11% +$137 ﹤0.01% 3947
2023
Q2
$1K Hold
55
﹤0.01% 3930
2023
Q1
$1K Hold
55
﹤0.01% 3791
2022
Q4
$1K Buy
55
+12
+28% +$242 ﹤0.01% 3710
2022
Q3
$1K Buy
+43
New +$758 ﹤0.01% 3616
2022
Q2
Sell
-66
Closed -$1K 3823
2022
Q1
$1K Buy
+66
New +$1.25K ﹤0.01% 3315

Other funds holding COLL

Carson Wealth (CWM LLC)'s COLL Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Collegium Pharmaceutical (COLL) stake by 8.1% in Q1 2026, buying an estimated $5.84K and bringing the position to 1,849 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Carson Wealth (CWM LLC) first reported a position in COLL in Q1 2022 and has held it in 16 quarters since. The position peaked at $79K in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,849 shares of Collegium Pharmaceutical worth $61.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 138 Collegium Pharmaceutical shares in Q1 2026, an estimated $5.84K.
  • Collegium Pharmaceutical made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3657 holding.
  • Carson Wealth (CWM LLC) first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 16 quarters since.
  • Carson Wealth (CWM LLC)'s Collegium Pharmaceutical position peaked at $79K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.